ChrysCapital, an investment firm that focuses on growth sectors in India, has sold its 11 percent stake in India-based prescription drug producer Mankind Pharma to Capital Group Private Markets, a global private equity investor, for INR13 billion (approximately US$203 million). The exit reportedly returned a 10x cash multiple to ChrysCapital.